Amazon buys Bee AI wearable that listens to everything you say
Bee makes a $49.99 Fitbit-like device that listens in on your conversations while using AI to transcribe everything that you and the people around you say, allowing it to generate personalized summaries of your days, reminders, and suggestions from within the Bee app. You can also give the device permission to access your emails, contacts, location, reminders, photos, and calendar events to help inform its AI-generated insights, as well as create a searchable history of your activities.
My colleague Victoria Song got to try out the device for herself and found that it didn't always get things quite right. It tended to confuse real-life conversations with the TV shows, TikTok videos, music, and movies that it heard. When asked about Amazon's plans to apply the same privacy measures offered by Bee, such as its policy against storing audio, Amazon spokesperson Alexandra Miller says the company 'cares deeply' about customer privacy and security.
'We've been strong stewards of customer data since our founding, and have never been in the business of selling our customers' personal information to others,' Miller says. 'We design our products to protect our customers' privacy and security and to make it easy for them to be in control of their experience — and this approach would of course apply to Bee.'
Miller also notes that the deal isn't yet closed, and its terms are 'confidential.' All Bee employees have 'received offers to join Amazon.'
Posts from this author will be added to your daily email digest and your homepage feed.
See All by Emma Roth
Posts from this topic will be added to your daily email digest and your homepage feed.
See All AI
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Amazon
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Gadgets
Posts from this topic will be added to your daily email digest and your homepage feed.
See All News
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Tech
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Wearable
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
a minute ago
- Bloomberg
Trump's Tariffs Are Already Stunting World Growth While Markets Shrug
As Donald Trump barrels toward his latest tariff deadline, the damage to the global economy from American protectionism is becoming increasingly evident, even if financial markets seem to have decided they can live with it. The US president has announced preliminary agreements with the European Union, Japan and a handful of others that raise tariff rates, and he's promising to impose even higher duties on Aug. 1 for countries that haven't cut deals. It all amounts to another step change in the trade barrier that Trump has erected around America, which is starting to reshape trade and investment patterns worldwide.
Forbes
a minute ago
- Forbes
The Risk Of Rushing: Details Murky On Trump, Van Der Leyen Trade Deal
President of the European Commission Ursula von der Leyen shakes hands with President during a ... More meeting at Trump Turnberry golf club on Sunday in Scotland. (Photo by) President Trump and European Union President Ursula von der Leyen shook hands on a deal Sunday to stave off 30% tariffs on U.S. imports from the E.U., which could have been effective on Friday, though it remains unclear what the deal is. Perhaps what they really agreed to is to stall for more time. Historically, trade agreements take a great deal of time and review before being announced. That said, it appears that most if not all U.S. imports from the European Union will face a 15% tariff. That's one area of disagreement if not among the two parties, then at least among the first reporting on the limited 'details.' It also appears that most U.S. exports to the 27 nations of the European Union will not have a tariff. That's another area of disagreement, at least in the early reporting. That 15% tariff on U.S. imports is up slightly from the 10% 'baseline' tariff already in place with all countries of the world since Trump began the global trade war to reduce the U.S. deficit, which is still increasing. It is, of course, significantly higher than the 1.2% tariff rate on U.S. imports from the European Union that preceded it. (The 'deal' would seem to lower the 25% tariff in place on passenger vehicle imports into the United States.) On the U.S. export side, the zero tariff rate would replace a rate of 2.8%, so not a big change. But a spokesperson for the European Union would not respond to a 'request for comment about Trump's claim." Here's where it gets really important: Does the 15% tariff on E.U. imports include critical medicines and the compounds used to make those medicines, imports into the United States that Ireland and other European nations dominate? President Trump says no, according to one news source. 'We have 15% for pharmaceuticals,' Von der Leyen said, according to another. I wrote last week about the risk of the trade war on Americans' access to important medicines because of the United States' reliance on Europe for so many medicines and a great deal of the chemical compounds used to produce drugs here. Regardless of whether pharmaceuticals are hit with 15% tariffs or not, it is not hard to imagine that whatever tariffs are ultimately imposed will put pressure on prices as the U.S. government collects revenues from the European Union and a host of other nations. One thing on which Trump and van der Leyen did agree was that making a deal was important to both sides, given the strength of the trading relationship. The United States' top 15 trade partners, which account for 44.40% of all U.S. trade, including 44.22% of all U.S. exports and 44.51% of all imports, includes the following seven European Union nations: Overall, the trade with just these European Union nations is relatively balanced, with those seven accounting for 21.38% of all U.S. trade, including 20.27% of all exports and 22.05% of all U.S. imports. The overall deficit with these five nations is $149.61 billion. The percentages for all 27 European nations is similar on total trade and U.S. exports but it drops on imports, since many of the other countries are without the same buying power. Overall, the European Union is accounting for 20.22% of all U.S. imports and 18.57% of all U.S. exports through May, the latest data available from the U.S. Census Bureau. Gaining clarity on the issues will be important. Six of the 10 U.S. imports from the European Union where the E.U. was a dominant source were in the area of pharmaceuticals and with chemical compounds used to make medicines in this country. The same six in 10 statistic is true of U.S. exports to the 27-nation European Union. For example, 99.22% of $42.95 billion in U.S. imports in the insulin, hormone and steroid category (HS code 2937) through May were from the European Union, with 98.48% coming from Ireland, according to my analysis of the latest U.S. Census Bureau data. It is the top U.S. import from the European Union this year. The same category is a top U.S. export to the European Union, accounting for 53.85% of the $4.94 billion in U.S. exports to the world, ranking fourth overall to the European Union. But the 15% tariffs would affect a broad range of exports and imports. The European Union is responsible for 79.77% of the $2.97 billion in wine imports into the United States through May and 80.78% of $2.15 billion in perfumes. While these are the U.S. import categories that the European Union dominates by global market share, they are not the largest by value. Among those not mentioned above for market share that are among the top 10 by value from the European Union are: It is, of course, not clear whether those last two would face tariffs or not. Switching over to the U.S. export side, the European Union has an appetite for the broad nut category (HS code 0802) that is dominated by shelled almonds and pistachios in the shell, with 37.49% of the $4.09 billion total in U.S. exports through May headed to the European Union. In addition, the E.U. has a thirst for the alcoholic spirits category (HS code 2208) that is dominated by bourbon and whiskey, with 46.66% of the total $1.08 billion sent to the world. Any decrease in tariffs on these would certainly be welcome. During the press conference announcing the framework for a deal, Trump emphasized that the European Union would be increasing its purchase of U.S. energy and, he hoped, cars. The European Union, Trump said, would be buying $750 billion in U.S. energy products, though it was not clear over what period of time or even which ones, specifically. In 2024, U.S. exports to the world of oil, gasoline and other refined petroleum products, and natural gas such as LNG – the dominant categories – was less than $300 billion. And most refined petroleum exports stay in the Western Hemisphere. But the European Union is a big market for U.S. exports of oil, petroleum gas and cars. One thing is clear: There is more work to be done before it is clear what the deal on which Trump and van der Leyen shook hands actually is.
Business Insider
13 minutes ago
- Business Insider
Alibaba (BABA) vs. Amazon (AMZN): Which E-Commerce Stock Has More Upside Ahead of Q2 Earnings?
The second-quarter earnings season is in full swing, and investors are closely watching global e-commerce leaders like Amazon (AMZN) and Alibaba (BABA) to assess the strength of consumer demand, the outlook for digital retail, and their growing role in artificial intelligence. Using TipRanks' Stock Comparison Tool, we will compare these two tech-powerhouse stocks to find the better pick ahead of the upcoming earnings results, according to Wall Street analysts. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Alibaba (NYSE:BABA) Stock Alibaba is China's largest e-commerce and cloud services company, operating platforms like Taobao, Tmall, and AliCloud. The stock has climbed over 39% so far this year, driven by strong gains in its AI-powered cloud services and growing demand for instant delivery. The company is doubling down on artificial intelligence, aiming to use it to transform online shopping and cloud services. It is using AI across its apps and cloud platform to improve customer experience and stay ahead of the competition. Looking ahead, the company is set to report its Q1 FY26 earnings next month. Wall Street expects Alibaba to report earnings of $2.22 per share for Q1, down 3% from the year-ago quarter. The decline could be due to the company's heavy investment in logistics and delivery. Meanwhile, analysts project Q1 revenues at $35.46 billion, up 6% year-over-year. Is Alibaba Stock a Good Buy Right Now? Ahead of the Q1 results, Benchmark's Top analyst Fawne Jiang reiterated her Buy rating with a $176 price target, implying a 47% gain from current levels. The analyst sees recent share weakness as a 'buying opportunity' and encourages investors to 'build exposure on dips,' confident in Alibaba's strong long-term growth outlook. Nevertheless, she expects Alibaba's margins and profits to come under pressure in the near term due to increased spending. As a result, Benchmark has cut its EBITDA forecast to RMB44 billion for Q1 FY26 and RMB208 billion for the full FY26, 'reflecting near-term margin pressure.' Overall, Wall Street has a Strong Buy consensus rating on Alibaba stock based on 14 Buys and one Hold rating. The average Alibaba price target of $151.08 implies about 26% upside potential from current levels. Amazon (NASDAQ:AMZN) Stock E-commerce and cloud computing giant Amazon is proving the resilience of its business model despite macro challenges and tariff woes. The stock has climbed over 5% so far this year. Several analysts remain bullish on Amazon's high-margin cloud unit, Amazon Web Services (AWS), which is expected to benefit from growing AI demand. In Q1 2025, AWS accounted for just 19% of revenue but delivered an impressive 63% of total operating profit. Meanwhile, Amazon's fast-expanding advertising segment is also emerging as a key growth engine. Looking ahead, Amazon is scheduled to announce its second-quarter results on July 31. Wall Street projects a 9% growth in Amazon's revenue to $162 million. Meanwhile, analysts expect the company to report earnings per share of $1.32 compared to $1.26 in the prior-year quarter. Is Amazon a Buy, Hold, or Sell? Ahead of the Q2 print, BofA Securities analyst Justin Post raised his price target to $265, up from $248, while maintaining a Buy rating. Post expects Amazon's Q2 retail performance to be strong, helped by positive credit card spending data and an extended Prime Day. He also believes AWS is picking up pace, with a strong order backlog and rising cloud demand. The analyst now predicts Q2 revenue of $164 billion, above Wall Street's estimate of $162.1 billion. Turning to Wall Street, AMZN stock has a Strong Buy consensus rating based on 44 Buys and one Hold assigned in the last three months. At $258.27, the average Amazon stock price target implies an 11.59% upside potential. Conclusion Ahead of earnings, Wall Street remains bullish on both Alibaba and Amazon stocks. However, analysts see greater upside potential in Alibaba, supported by its strong fundamentals, expanding AI initiatives, and solid recovery in e-commerce business. Meanwhile, Amazon is gaining from steady growth in cloud and advertising, two high-margin areas set to benefit from AI. While its upside may be smaller than Alibaba's, Amazon's stable growth and strong cash flow continue to earn Wall Street's confidence.
